FINHUB Insights

ABBV · Q4 FY25 · Oct 1 – Dec 31, 2025

AbbVie Q4 FY25: where the revenue came from and where it went

AbbVie Q4 FY25: revenue $16.6B (+10% year over year). Net profit $1.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Oct 1 – Dec 31, 2025
Reported
Feb 20, 2026 10-K
Sankey diagram of AbbVie's income statement for Q4 FY25: revenue of $16.6 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$16.6B +10% year over year
Gross profit$12.1B 73% margin
Operating profit$4.5B 27% margin
Net profit$1.8B 11% margin

The numbers

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
ItemValueShare of revenueYear over year
Revenue 16.6 100% +10%
Cost of revenue−4.627%
Gross profit12.173% margin+2pp
SG&A−3.923%−2pp
Other−3.622%+0pp
Operating profit4.527% margin+37pp
Tax−0.9
Interest & other costs−1.9
Net profit1.811%+11pp
Filing on EDGAR More quarters of ABBV

Source of the numbers: tables in the filing (10-K). The diagram is generated automatically and checked against EDGAR before release. The fourth quarter has no column of its own in an annual report, so it is the full year minus the first nine months. How we calculate it → About and methodology.